230 related articles for article (PubMed ID: 21792548)
1. Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study.
Ercan Ş; Kaymaz Ö; Yücel N; Orçun A
Arch Gynecol Obstet; 2012 Mar; 285(3):579-84. PubMed ID: 21792548
[TBL] [Abstract][Full Text] [Related]
2. The effect of maternal age, parity, and fetal sex on the amniotic fluid and maternal serum levels of CA 125, CA 19.9, CA 15.3, and CEA.
Tayyar M; Tutus A
Int J Fertil Womens Med; 1999; 44(5):256-9. PubMed ID: 10569455
[TBL] [Abstract][Full Text] [Related]
3. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
[TBL] [Abstract][Full Text] [Related]
4. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
Ayhan A; Guven S; Guven ES; Kucukali T
Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
[TBL] [Abstract][Full Text] [Related]
5. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
6. Significance of serum tumor markers carcinoembryonic antigen, CA 19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation.
Pissaia A; Bernard D; Scatton O; Soubrane O; Conti F; Calmus Y
Transplant Proc; 2009 Mar; 41(2):682-4. PubMed ID: 19328956
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of tumour markers in molar pregnancy.
Hegab HM; Schindler AE; Rizk M; Ramadan M
Arch Gynecol Obstet; 2003 Aug; 268(3):151-4. PubMed ID: 12942241
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up study in breast cancer patients using serum tumor markers CEA and CA 15-3.
Lumachi F; Brandes AA; Boccagni P; Polistina F; Favia G; D'Amico DF
Anticancer Res; 1999; 19(5C):4485-9. PubMed ID: 10650797
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal determination of serum placental protein 13 during development of preeclampsia.
Huppertz B; Sammar M; Chefetz I; Neumaier-Wagner P; Bartz C; Meiri H
Fetal Diagn Ther; 2008; 24(3):230-6. PubMed ID: 18753763
[TBL] [Abstract][Full Text] [Related]
10. Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder.
Ahmadi H; Djaladat H; Cai J; Miranda G; Daneshmand S
Urol Oncol; 2014 Jul; 32(5):648-56. PubMed ID: 24680660
[TBL] [Abstract][Full Text] [Related]
11. Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer.
Lumachi F; Basso SM; Bonamini M; Marzano B; Milan E; Waclaw BU; Chiara GB
Anticancer Res; 2010 Jun; 30(6):2331-4. PubMed ID: 20651388
[TBL] [Abstract][Full Text] [Related]
12. A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
Guadagni F; Ferroni P; Carlini S; Mariotti S; Spila A; Aloe S; D'Alessandro R; Carone MD; Cicchetti A; Ricciotti A; Venturo I; Perri P; Di Filippo F; Cognetti F; Botti C; Roselli M
Clin Cancer Res; 2001 Aug; 7(8):2357-62. PubMed ID: 11489813
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
14. Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors.
Lahdenne P; Pitkänen S; Rajantie J; Kuusela P; Siimes MA; Lanning M; Heikinheimo M
Pediatr Res; 1995 Nov; 38(5):797-801. PubMed ID: 8552451
[TBL] [Abstract][Full Text] [Related]
15. CEA and CA 19-9 as prognostic indexes in colorectal cancer.
Forones NM; Tanaka M
Hepatogastroenterology; 1999; 46(26):905-8. PubMed ID: 10370636
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer markers during normal pregnancy.
Botsis D; Sarandakou A; Kassanos D; Kontoravdis A; Rizos D; Protonotariou E; Phocas I; Creatsas G
Anticancer Res; 1999; 19(4C):3539-41. PubMed ID: 10629649
[TBL] [Abstract][Full Text] [Related]
17. Increased serum CA-15.3 levels in patients with megaloblastic anemia due to vitamin B12 deficiency.
Symeonidis A; Kouraklis-Symeonidis A; Apostolopoulos D; Arvanitopoulou E; Giannakoulas N; Vassilakos P; Zoumbos N
Oncology; 2004; 67(5-6):359-67. PubMed ID: 15713991
[TBL] [Abstract][Full Text] [Related]
18. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
[TBL] [Abstract][Full Text] [Related]
19. Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas?
Thomakos N; Rodolakis A; Zagouri F; Zacharakis D; Sotiropoulou M; Akrivos N; Haidopoulos D; Papadimitriou CA; Dimopoulos MA; Antsaklis A
Arch Gynecol Obstet; 2013 Jan; 287(1):97-102. PubMed ID: 22941327
[TBL] [Abstract][Full Text] [Related]
20. Measurement of tumor markers in chronic hemodialysis patients.
Tzitzikos G; Saridi M; Filippopoulou T; Makri A; Goulioti A; Stavropoulos T; Stamatiou K
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):50-3. PubMed ID: 20061692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
